Studies
| Study First Submitted Date | 2021-11-16 |
| Study First Posted Date | 2022-03-31 |
| Last Update Posted Date | 2022-10-14 |
| Verification Month Year | October 2022 |
| Verification Date | 2022-10-31 |
| Last Update Posted Date | 2022-10-14 |
Id Information
| Sequence: | 40034360 |
| Id Source | org_study_id |
| Id Value | CA011-011 |
Countries
| Sequence: | 42430464 | Sequence: | 42430465 | Sequence: | 42430466 | Sequence: | 42430467 | Sequence: | 42430468 | Sequence: | 42430469 | Sequence: | 42430470 |
| Name | Australia | Name | France | Name | Italy | Name | New Zealand | Name | Sweden | Name | Switzerland | Name | United States |
| Removed | True | Removed | True | Removed | True | Removed | True | Removed | True | Removed | True | Removed | True |
Interventions
| Sequence: | 52324805 |
| Intervention Type | Drug |
| Name | BET Inhibitor |
| Description | Bromodomain and Extra-Terminal Inhibitor |
Sponsors
| Sequence: | 48171037 |
| Agency Class | INDUSTRY |
| Lead Or Collaborator | lead |
| Name | Bristol-Myers Squibb |
Overall Officials
| Sequence: | 29194059 |
| Role | Study Director |
| Name | Bristol-Myers Squibb |
| Affiliation | Bristol-Myers Squibb |
Eligibilities
| Sequence: | 30672277 |
| Minimum Age | N/A |
| Maximum Age | N/A |
| Adult | True |
| Child | True |
| Older Adult | True |
Calculated Values
| Sequence: | 254302832 |
| Registered In Calendar Year | 2021 |
| Were Results Reported | False |
| Has Single Facility | False |
Links
| Sequence: | 4373836 | Sequence: | 4373837 | Sequence: | 4373838 | Sequence: | 4373839 |
| Url | https://www.bms.com/healthcare-providers/early-patient-access-to-investigational-medicine/investigational-drugs-available.html | Url | https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html | Url | https://www.bmsstudyconnect.com/s/US/English/USenHome | Url | https://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm |
| Description | Pre-Approval Access (PAA) Healthcare Practitioner Requests | Description | BMS Clinical Trial Information | Description | BMS Clinical Trial Patient Recruiting | Description | FDA Safety Alerts and Recalls |
Responsible Parties
| Sequence: | 28785564 |
| Responsible Party Type | Sponsor |